ROCCHICCIOLI, SILVIA
 Distribuzione geografica
Continente #
AS - Asia 2.519
NA - Nord America 1.730
EU - Europa 810
SA - Sud America 383
AF - Africa 40
OC - Oceania 4
Totale 5.486
Nazione #
US - Stati Uniti d'America 1.655
SG - Singapore 1.058
CN - Cina 541
BR - Brasile 313
HK - Hong Kong 300
IT - Italia 274
VN - Vietnam 252
FR - Francia 137
NL - Olanda 104
JP - Giappone 77
KR - Corea 75
FI - Finlandia 64
DE - Germania 51
IN - India 51
GB - Regno Unito 49
BD - Bangladesh 37
AR - Argentina 30
CA - Canada 30
MX - Messico 23
TR - Turchia 19
ES - Italia 18
IQ - Iraq 17
AT - Austria 16
ID - Indonesia 14
PL - Polonia 13
SE - Svezia 13
IL - Israele 12
UZ - Uzbekistan 12
RU - Federazione Russa 11
IR - Iran 10
MA - Marocco 10
IE - Irlanda 9
ZA - Sudafrica 9
JM - Giamaica 8
CL - Cile 7
CO - Colombia 7
VE - Venezuela 7
AZ - Azerbaigian 6
EC - Ecuador 6
GR - Grecia 6
PK - Pakistan 6
SA - Arabia Saudita 6
TN - Tunisia 6
AL - Albania 5
BO - Bolivia 5
KZ - Kazakistan 5
LT - Lituania 5
PH - Filippine 5
UA - Ucraina 5
AU - Australia 4
DO - Repubblica Dominicana 4
EE - Estonia 4
KE - Kenya 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
HN - Honduras 3
PE - Perù 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
BE - Belgio 2
CH - Svizzera 2
CY - Cipro 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
HR - Croazia 2
LB - Libano 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
HU - Ungheria 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MV - Maldive 1
MW - Malawi 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
SI - Slovenia 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 5.486
Città #
Singapore 621
Santa Clara 396
Hong Kong 295
San Jose 231
Hefei 181
Beijing 153
Ashburn 143
Los Angeles 134
Dallas 125
Lauterbourg 109
Ho Chi Minh City 97
Seoul 72
Tokyo 62
Hanoi 54
New York 43
Pisa 38
São Paulo 27
Modena 26
Buffalo 23
Helsinki 23
Lappeenranta 23
Cascina 22
Orem 22
Milan 18
Turku 18
Frankfurt am Main 16
Phoenix 14
Rio de Janeiro 14
Haiphong 13
London 13
Montreal 13
Atlanta 12
Livorno 11
Munich 11
Stockholm 11
Tashkent 11
Belo Horizonte 10
Biên Hòa 10
Council Bluffs 10
Denver 10
Nuremberg 10
Warsaw 10
Bengaluru 9
Brooklyn 9
Chennai 9
Florence 9
Minamishinagawa 9
Naples 9
Boston 8
Chicago 8
Dublin 8
Istanbul 8
Manchester 8
Mumbai 8
Brasília 7
Dhaka 7
Düsseldorf 7
Johannesburg 7
Mexico City 7
San Francisco 7
Ankara 6
Charlotte 6
Da Nang 6
Hyderabad 6
Indianapolis 6
Porto Alegre 6
Vienna 6
Amsterdam 5
Athens 5
Baghdad 5
Bologna 5
Casablanca 5
Casalmaggiore 5
City of London 5
Curitiba 5
Hải Dương 5
Madrid 5
Newark 5
Paris 5
Poplar 5
Shanghai 5
Baku 4
Columbus 4
Houston 4
Manaus 4
Osasco 4
Piscataway 4
Quận Một 4
Toronto 4
Acalanes Ridge 3
Araruama 3
Boardman 3
Brescia 3
Bắc Ninh 3
Bến Tre 3
Campinas 3
Cardito 3
Catania 3
Detroit 3
Genoa 3
Totale 3.476
Nome #
SMARTool: Interim Progress Report (M19-M30) 127
The Clinical Utility of the Saliva Proteome in Rare Diseases: A Pilot Study for Biomarker Discovery in Primary Sclerosing Cholangitis 114
Health improvements by Understanding Residual Risk In CAd and NEw targets for prevention/treatment: Rationale and Research Protocol of the HURRICANE project 110
SMARTool - Periodic Technical Report - PART B (Period 2) 109
Dem-Aging: autophagy-related pathologies and the “two faces of dementia” 96
Plasma lipidomics and coronary plaque changes: a substudy of the SMARTool clinical trial 96
Homotypic targeting and drug delivery in glioblastoma cells through cell membrane-coated boron nitride nanotubes 94
Validated models for pre-test probability of stable coronary artery disease: a systematic review suggesting how to improve validation procedures 85
Association of circulating neutrophils with relative volume of lipid-rich necrotic core of coronary plaques in stable patients: a substudy of SMARTool european project 84
Discrimination capability of pretest probability of stable coronary artery disease: a systematic review and meta-analysis suggesting how to improve validation procedures 80
Proteomic Modulation in TGF-b-Treated Cholangiocytes Induced by Curcumin Nanoparticles 79
Effect of Neutrophil–Platelet Interactions on Cytokine-Modulated Expression of Neutrophil CD11b/CD18 (Mac-1) Integrin Complex and CCR5 Chemokine Receptor in Stable Coronary Artery Disease: A Sub-Study of SMARTool H2020 European Project 78
Saliva Proteome of Primary Sclerosing Cholangitis: A Pilot Study to demonstrate its clinical utility 76
Blood M2-like Monocyte Polarization Is Associated with Calcific Plaque Phenotype in Stable Coronary Artery Disease: A Sub-Study of SMARTool Clinical Trial 76
A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome 75
Targeting autophagy impairment improves the phenotype of a novel CLN8 zebrafish model 72
Blood Monocyte Phenotype Fingerprint of Stable Coronary Artery Disease: A Cross-Sectional Substudy of SMARTool Clinical Trial 72
Predictive added value of selected plasma lipids to a re-estimated minimal risk tool 69
Lysosomal Proteomics Links Disturbances in Lipid Homeostasis and Sphingolipid Metabolism to CLN5 Disease 69
Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina 66
Ceramides as mediators of oxidative stress and inflammation in cardiometabolic disease 66
Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS) 66
Lipidomic analysis to assess the correlation between ceramides, stress hyperglycemia, and HbA1c in acute myocardial infarction 64
INSILC D9.2. - HCT - Requirement No. 2 61
Maternal Obesity and Cardiac Development in the Offspring Study in Human Neonates and Minipigs 60
A targeted LC-MS/MS analysis of circulatory lipid profile to highlight biomarkers for patient stratification according to coronary artery disease severity 60
A different trend of heat shock proteins 90 mRNA and protein in hepatocellular carcinoma cell line-secreted extracellular vesicles. 59
Rhodium catalyzed hydroformylation of beta-isophorone: an unexpected result 58
Chiral N-Allylpyrroles as Versatile Substrates Under Rhodium Catalyzed Hydroformylation: Good Regio- and Diastereo Selectivity at Room Temperature and High Pressure 57
Molecular characterization of plasma HDL, LDL, and VLDL lipids cargos from atherosclerotic patients with advanced carotid lesions: a preliminary report 57
Tangier disease: a plasma proteome approach 56
Ceramides and Cardiovascular Risk Factors, Inflammatory Parameters and Left Ventricular Function in AMI Patients 56
Transcriptional level evaluation of osteopontin/miRNA-181a axis in hepatocellular carcinoma cell line-secreted extracellular vesicles 56
Low leptin plasma levels are associated with progression of coronary atherosclerosis in patients with stable coronary artery disease from the SMARTool Study 55
Salivary proteomics markers for preclinical Sjögren's Syndrome: a pilot study 55
Biological effects of Transforming Growth Factor Beta in human cholangiocytes 55
Integrative human and murine multi-omics: Highlighting shared biomarkers in the neuronal ceroid lipofuscinoses 54
SMARTool: Periodic Technical Report - Part B 54
Proof of concept of a new plasma complement Factor H from waste plasma fraction 53
Innate Immunity and Coronary Atherosclerosis Progression: putative cellular and molecular marker. 53
Lipid biomarkers in statin users with coronary artery disease annotated by coronary computed tomography angiography 53
Protein Delivery by Peptide-Based Stealth Liposomes: A Biomolecular Insight into Enzyme Replacement Therapy 52
Brain histone beta-hydroxybutyrylation couples metabolism with gene expression 52
Relazione 3 (finale): Relazione finale protocollata e stesura di un protocollo analitico definitivo con gli step raggiunti su metodo per analisi quantitativa HPLC-QTRAP 52
A gel-free approach in vascular smooth muscle cell proteome: perpectives for a better insight into activation 52
Biohumoral predictors of coronary atherosclerosis progression in patients with suspected coronary artery disease from the SMARTool Study 50
SMARTool - Interim Report M19-M24 50
Comparative proteomics profiling through DIA-SWATH-MS analysis in WT vs PPT1 KO "neuron-like" human cell lines as CLN1 model 50
Cardiac troponins: Mechanisms of release and role in healthy and diseased subjects 49
A targeted LC-MS/MS analysis of the human plasma lipid profile to highlight novel markers of coronary artery disease severity 49
Impact of Clinical Characteristics and Statins on Coronary Plaque Progression by Serial Computed Tomography Angiography 47
Elevated triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina. 47
Medium-term effect of sublingual L-glutathione supplementation on flow-mediated dilation in subjects with cardiovascular risk factors 47
Proteomic analyses and integrative omics approach to highlight the common molecular signatures for different NCL forms 47
Low T3 State Is Correlated with Cardiac Mitochondrial Impairments after Ischemia Reperfusion Injury: Evidence from a Proteomic Approach. 46
Proteomics pipeline for phosphoenrichment and its application on a human melanoma cell model 45
Rational Design of a Transferrin-Binding Peptide Sequence Tailored to Targeted Nanoparticle Internalization 45
Characterization of secreted vesicles from vascular smooth muscle cells 44
Apolipoprotein E ?4 triggers neurotoxicity via cholesterol accumulation, acetylcholine dyshomeostasis, and PKC? mislocalization in cholinergic neuronal cells 44
Metodo per la separazione dei costituenti di miscele complesse di proteine da sottoporre ad analisi proteomica e apparecchiatura che attua tale metodo 44
Proteomics changes in adhesion molecules: a driving force for vascular smooth muscle cell phenotypic switch 43
A common plasma lipidomics signature of cardiometabolic and coronary risk in statin users 43
Biological and Proteomic characterization of a composite mesh for abdominal wall hernia treatment: Reference Study 43
The landscape of BRAF transcript and protein variants in human cancer 43
Secretome modulation by high-cholesterol diet in pig coronary arteries 42
Modulated molecular markers of restenosis and thrombosis by in-vitro vascular cells exposed to bioresorbable scaffolds 41
Proteomics and lipidomic analysis reveal dysregulated pathways associated with loss of sacsin 41
Characterization of Extracellular Vesicle Cargo in Sjogren's Syndrome through a SWATH-MS Proteomics Approach 40
Secreted proteins from carotid endarterectomy: an untargeted approach to disclose molecular clues of plaque progression 40
HDL-Mediated Protection of Coronary Vasodilator Response to Adenosine in the Hypercholesterolemic Swine. 40
Site-specific secretome map evidences VSMC-related markers of coronary atherosclerosis grade and extent in the hypercholesterolemic swine 40
Integration of Biomechanical and Biological Characterization in the Development of Porous Poly(caprolactone)-Based Membranes for Abdominal Wall Hernia Treatment 40
CMC composite mesh: biological characterization, proteomic analysis and anisotropy as reference study for "MES-STAR" Manunet II - European research project 39
Coronary vascular smooth muscle cell proteins in the hypercholesterolemic swine: plaque-related markers of accelerated atherogenesis 39
Proteomics Techniques for the Detection of Translated Pseudogenes 39
FOCUS ON RELEASED EXTRACELLULAR MATRIX COMPONENTS FROM CAROTID PLAQUE CORE: INTACT PROTEINS OR FRAGMENTS? 38
RISC-mediated control of selected chromatin regulators stabilizes ground state pluripotency of mouse embryonic stem cells 38
Quantitative CTA analysis of coronary plaque progression in SMARTool clinical study: the association between baseline clinical parameters and plaque progression 36
An automated plasma protein fractionation design: High-throughput perspectives for proteomic analysis 35
Quantitative CTA Analysis of Coronary Plaque Progression in SMARTool Clinical Study: The Association Between Baseline Clinical Parameters and Plaque Progression 35
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes. 34
CMC COMPOSITE MESH: BIOLOGICAL CHARACTERIZATION, PROTEOMIC ANALYSIS AND ANISOTROPY AS REFERENCE STUDY FOR "MES­STAR" MANUNET II ­ EUROPEAN RESEARCH PROJECT 34
Synthesis of 5,6,7,8-tetrahydroindolizines via a domino-Type transformation based on the rhodium catalyzed hydroformylation of N-(â-methallyl)pyrroles 34
Vascular smooth muscle cell proteome changes in a high fat diet animal model of atherogenesis 34
Inflammation blood and tissue factors of plaque growth in an experimental model evidenced by a systems approach 33
From chiral and prochiral N-allylpyrroles to stereodefined pyrrole fused architectures: a particular application of the rhodium catalyzed hydroformylation 33
CMC COMPOSITE MESH: BIOCHEMICAL AND BIOMECHANICAL ANALYSIS 33
Complete 1,3-asymmetric induction into 3-methyl-(3-acetylpyrrol-1-yl)butanal to 1-acetyl-6-methyl-8-hydroxy-5,6,7,8-tetrahydroindolizine cyclization 32
Dysregulated autophagy as a new aspect of the molecular pathogenesis of Krabbe disease 31
Non-Invasive Prediction of Site-Specific Coronary Atherosclerotic Plaque Progression using Lipidomics, Blood Flow, and LDL Transport Modeling 30
Computational prediction of the regio- and diastereoselectivity in a rhodium-catalyzed hydroformylation/cyclization domino process 30
Proteomics and personalized medicine 30
[18F]insulin for PET imaging applications: simple and chemoselective two step reaction based on combined microfluidic-vessel chemistry 30
Sex differences in coronary plaque changes assessed by serial computed tomography angiography 29
A gel-free approach in vascular smooth muscle cell proteome: perspectives for a better insight into activation 28
SmartFFR, a New Functional Index of Coronary Stenosis: Comparison With Invasive FFR Data 27
VASCULAR SMOOTH-MUSCLE-CELL ACTIVATION: PROTEOMICS POINT OF VIEW 27
Ribozyme-mediated gene knock down strategy to dissect the consequences of PDGF stimulation in vascular smooth muscle cells. 27
Evidence for formation and different evolution of tertiary rhodium alkyl intermediates under rhodium-catalyzed deuterio-(hydro)formylation of 1-(n-pyridyl)-1-phenylethenes 26
Machine Learning Coronary Artery Disease Prediction Based on Imaging and Non-Imaging Data 26
Totale 5.250
Categoria #
all - tutte 18.498
article - articoli 14.676
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 238
Totale 33.412


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202499 0 0 0 0 0 0 0 0 10 65 23 1
2024/20252.125 56 16 164 68 411 78 69 152 120 149 486 356
2025/20263.477 183 276 339 508 671 165 552 107 188 280 177 31
Totale 5.701